Exhibit 1
Joint Filing Agreement
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the shares of common stock of Clarus Therapeutics Holdings, Inc. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of September 24, 2021. This Agreement may be executed in any number of counterparts, all of which, taken together, shall constitute one and the same instrument.
| CBC SPVI Ltd |
| By: | /s/ Wei FU | |
| Name: | Wei FU | |
| Title: | Director |
| C-Bridge Healthcare Fund, L.P. |
| By: | /s/ Wei FU | |
| Name: | Wei FU | |
| Title: | Authorized Representative |
| C-Bridge Healthcare Fund GP, L.P. |
| By: | /s/ Wei FU | |
| Name: | Wei FU | |
| Title: | Authorized Representative |
| C-Bridge Capital GP, Ltd. |
| By: | /s/ Wei FU | |
| Name: | Wei FU | |
| Title: | Director |
| Wei FU |
| By: | /s/ Wei FU |
